XNCR Q4 2024 Earnings — Xencor, Inc. Revenue & Financial Results | Market Cap Arena

XNCRXencor, Inc.

$890M

Q4 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$70M+37.4% YoY

Gross Profit

$70M100.0% margin

Operating Income

$4M5.8% margin

Net Income

-$53M-76.4% margin

EPS (Diluted)

$-0.73

QoQ Revenue Growth

+293.4%

Cash Flow

Operating Cash Flow

-$56M

Free Cash Flow

-$58M

Stock-Based Comp.

$12M

Balance Sheet

Total Assets

$952M

Total Liabilities

$278M

Stockholders' Equity

$678M

Cash & Equivalents

$41M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$70M	$51M	+37.4%
Gross Profit	$70M	$48M	+46.7%
Operating Income	$4M	-$29M	+114.1%
Net Income	-$53M	-$26M	-104.5%

Revenue Segments

Milestone

$34M100%